Evaluates trypanocidal activity of nitroheterocyclic adamantanohydrazones, suggesting effective treatment candidates.
Extending our research on the design, synthesis, and pharmacological evaluation of antitrypanosomatid nitroheterocyclic aromatic adamantanes, we have identified hydrazone derivatives conjugated with 5-nitrothiophene that have submicromolar activity against trypanosomes. Key structural features, namely, the incorporation of the adamantane ring into the skeleton of the new compounds, the nature and the length of the hydrazone linker, and the nitroheterocycle moiety were evaluated to optimize both efficacy and safety profiles. It is also shown that these compounds function as prodrugs that are bioactivated by parasite-specific nitroreductase enzymes, primarily NTR-1. These findings suggest that nitroheterocyclic aromatic adamantanohydrazones represent promising candidates for further development as antitrypanosomal agents.
No takes yet. Share an insight, caveat, or question.
Foscolos et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: